On May 22, 2014, Move Inc. (NASDAQ:MOVE) promotes Luke Glass to the new position of executive vice president of industry platforms. Glass is responsible for leading the company’s real estate industry relations efforts and supporting Move’s industry strategy. Move Inc. (NASDAQ:MOVE) shares after opening at $11.23 on last trade day and at the end of the day closed at $12.30. Company price to sales ratio in past twelve months was calculated as 2.11 and price to cash ratio as 4.21. Move Inc. (NASDAQ:MOVE) showed a positive weekly performance of 20.71%.
Microvision, Inc. (NASDAQ:MVIS) announced its operating and financial results for the first quarter of 2014 and the advancement of its 2014 business objectives. MicroVision made strong progress in the first quarter related to its operating goals for 2014. The goals for the year include: Complete display module development with Fortune Global 100 customer, support customer with commercialization efforts and supply key components. Microvision, Inc. (NASDAQ:MVIS) shares advanced 6.47% in last trading session and ended the day on $1.81. MVIS return on assets is -133.00%. Microvision, Inc. (NASDAQ:MVIS) yearly performance is 42.52%.
On May 9, 2014, China Finance Online Co. (ADR) (NASDAQ:JRJC) announced that it expects to report net revenues of $21.0 million for the first quarter of 2014, up 281.8% from $5.5 million in the first quarter of 2013. The expected net revenues reflect the impact of fewer trading days in the first quarter due to the long Chinese New Year holidays. China Finance Online Co. (ADR) (NASDAQ:JRJC) shares moved up 23.98% in last trading session and was closed at $3.05, while trading in range of $2.45 – $3.23. China Finance Online Co. (ADR) (NASDAQ:JRJC) year to date (YTD) performance is -51.51%.
Galena Biopharma Inc (NASDAQ:GALE) announced that Ryan Dunlap, Vice President and Chief Financial Officer, will present a corporate update at the Marcum MicroCap Conference. The presentation will take place on Thursday, May 29, 2014 at 10:00 a.m. ET at The Grand Hyatt Hotel in New York City. Galena Biopharma Inc (NASDAQ:GALE) weekly performance is 5.99%. On last trading day company shares ended up $2.30. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -3.61%. Analysts mean target price for the company is $6.88.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) presented encouraging data on its oncology candidate Ad-RTS-IL-12 at the annual meeting of the American Society of Gene and Cell Therapy (:ASGCT). ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) weekly performance is 4.67%. On last trading day company shares ended up $3.36. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP distance from 50-day simple moving average (SMA50) is -12.96%. Analysts mean target price for the company is $7.00.